SD:NYSESandRidge Energy, Inc. Analysis
Data as of 2026-07-08 - not real-time
$13.47
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
SandRidge Energy is trading at $13.47, comfortably below its 20‑day ($14.05), 50‑day ($14.71) and 200‑day ($14.58) moving averages, with an RSI of 40 and a bearish MACD histogram, suggesting short‑term pressure near the $13.05 support level. Volume is rising and the Fear & Greed Index reads 89 (Extreme Greed), indicating market optimism despite the technical weakness.
Fundamentally, the company posted 16.8% revenue growth to $163.5 M, a 31% jump in oil production and a 4% rise in total output, delivering a 46% profit margin and a forward‑looking PE of 6.57 versus an industry average of 20.67. With $102.7 M in cash, virtually no debt, a 3.86% dividend yield and a modest 23% payout, the balance sheet is strong and the dividend appears sustainable.
Fundamentally, the company posted 16.8% revenue growth to $163.5 M, a 31% jump in oil production and a 4% rise in total output, delivering a 46% profit margin and a forward‑looking PE of 6.57 versus an industry average of 20.67. With $102.7 M in cash, virtually no debt, a 3.86% dividend yield and a modest 23% payout, the balance sheet is strong and the dividend appears sustainable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above the $13.05 support level
- Bearish MACD and neutral RSI indicating limited upside
- High 30‑day volatility (~38%) may cause price swings
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings momentum: revenue up 16.8% and adjusted EBITDA up 32% YoY
- Attractive valuation: PE 6.57 vs industry 20.67 and P/B below 1
- Sustainable dividend yield of 3.86% with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Debt‑free balance sheet and $102.7 M cash cushion
- Consistent production growth and high profit margins
- Long‑term exposure to U.S. Mid‑Continent oil & gas assets with low geographic risk
Key Metrics & Analysis
Financial Health
Revenue Growth16.80%
Profit Margin46.37%
P/E Ratio6.6
ROE15.30%
ROA6.40%
Debt/Equity0.32
P/B Ratio0.9
Op. Cash Flow$99.6M
Free Cash Flow$-6447875
Industry P/E20.7
Technical Analysis
TrendNeutral
RSI40.1
Support$13.05
Resistance$15.53
MA 20$14.05
MA 50$14.71
MA 200$14.58
MACDBearish
VolumeIncreasing
Fear & Greed Index89.16
Valuation
Fair Value$52.56
Target Price$15.00
Upside/Downside11.36%
GradeUndervalued
TypeBlend
Dividend Yield3.86%
Risk Assessment
Beta-0.21
Volatility38.64%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.